Back

Impact of inflammatory phenotype on prognostic discrimination for the novel biomarker cellular communication network factor 1 (CCN1) in patients with dilated cardiomyopathy

27 August 2022 (17:15 - 18:00)
Organised by:
Congress Presentation Part of: Biomarkers for heart failure 1 Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Roland Klingenberg

Hospital Nordwest, Frankfurt (Germany)

6 More presentations in this session

Presentation thumbnail
NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy
Doctor O. Wozniak (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction
Doctor J. Cunningham (Boston, US)
Abstract Slides
Presentation thumbnail
Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF Study
Doctor M. Iguchi (Kyoto, JP) Professor K. Hasegawa (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure
Doctor R. Pistulli (Munster, DE)
Abstract Slides
Presentation thumbnail
Heart failure is associated with low circulating levels of secreted frizzled receptor protein 5 (Sfrp5).
Mr C. Kelly (Newcastle, AU)
Abstract Slides

Access the full session

Session thumbnail
Biomarkers for heart failure 1

The Event

Event poster

ESC Congress 2022

27 August 2022 17:15 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources